Optimizing Genetic Testing Prior Authorizations with Waystar Clearinghouse

The Genetic Testing Prior Authorization Landscape with Waystar

Genetic testing, encompassing hereditary cancer panels, prenatal diagnostics, and pharmacogenomics, often triggers complex prior authorization requirements. These services are high-cost and frequently routed through specialty benefit managers (RBMs) like eviCore and Avalon Healthcare Services, adding layers of complexity to the Waystar Clearinghouse submission process. Klivira automates the collection and submission of the specific clinical documentation required by these RBMs, ensuring Waystar receives complete data for payer adjudication.

Key Prior Authorization Triggers in Genetic Testing

• Hereditary cancer panels (e.g., BRCA1/2, Lynch Syndrome panels)
• Prenatal genetic testing (e.g., NIPT, carrier screening for CF, SMA)
• Pharmacogenomic testing for drug-gene interactions
• Whole exome/genome sequencing
• Specific gene sequencing for rare diseases

EMR and Payer Touchpoints in the Waystar Workflow

Genetic testing orders originate in the EMR, often requiring specific order types and clinical templates to capture family history, previous test results, and physician notes. Klivira integrates directly with EMR systems via SMART on FHIR, extracting relevant data. This data is then formatted for seamless transmission through Waystar, leveraging standard transactions such as X12 278 for electronic prior authorization (ePA) submissions to various payer channels, including direct portals and Da Vinci PAS endpoints.

Clinical Guidelines and Evidence Integration

Prior authorization for genetic testing is heavily informed by evolving clinical evidence and guideline bodies. Payers frequently reference criteria from organizations such as the National Comprehensive Cancer Network (NCCN) for hereditary cancer, the American College of Medical Genetics and Genomics (ACMG) for prenatal screening, and other specialty-specific guidelines. Klivira's platform incorporates these dynamic clinical rules, assisting providers in aligning documentation with payer-specific medical policies before submission through Waystar.

Streamlining the Genetic Testing Waystar Clearinghouse Workflow with Klivira

Klivira acts as an intelligent layer, orchestrating the prior authorization workflow between your EMR, the Waystar Clearinghouse, and ultimately, the payers and RBMs. Our platform automates the identification of PA requirements, compiles necessary clinical documentation, and monitors submission status. This reduces manual intervention, accelerates turnaround times, and minimizes the administrative burden on your revenue cycle and prior authorization teams.

Benefits of Klivira for Genetic Testing PA via Waystar

• Automated identification of PA requirements for genetic tests.
• Efficient data extraction from EMRs for Waystar submission.
• Pre-submission validation against payer and RBM clinical criteria.
• Real-time status tracking of prior authorizations submitted via Waystar.
• Reduced administrative overhead and improved staff efficiency.
• Enhanced clean claim rates and accelerated revenue cycles.